Long noncoding RNA CCAT2 as a novel biomaker of metastasis and prognosis in human cancer: a meta-analysis-Reference-Cited by-同舟云学术

Long noncoding RNA CCAT2 as a novel biomaker of metastasis and prognosis in human cancer: a meta-analysis

Published:2017-05-24 Issue:43 Volume:8 Page:75664-75674
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wang Dailian¹²,Chen Zhicong¹³,Xu Haidan¹,He Anbang¹⁴,Liu Yuchen¹,Huang Weiren¹

Affiliation:

1. Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China

2. Guangzhou Medical University, Guangzhou, Guangdong ,China

3. Shantou University Medical College, Shantou, Guangdong, China

4. Anhui Medical University, Hefei, Anhui, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting long non-coding RNAs in cancer therapy using CRISPR-Cas9 technology: A novel paradigm for precision oncology;Journal of Biotechnology;2024-01

2. Long non-coding RNA colon cancer-associated transcript 2: role and function in human cancers;Chinese Medical Journal;2022-09-08

3. Tumor Targeted Polymer Nanoparticles Co-loaded with Docetaxel and siCCAT2 for Combination Therapy of Lung Cancer;Journal of Drug Targeting;2021-12-21

4. The Roles of the Colon Cancer Associated Transcript 2 (CCAT2) Long Non-Coding RNA in Cancer: A Comprehensive Characterization of the Tumorigenic and Molecular Functions;International Journal of Molecular Sciences;2021-11-19

5. The transcribed ultraconserved element uc.51 promotes the proliferation and metastasis of breast cancer by stabilizing NONO;Clinical & Experimental Metastasis;2021-10-29